Literature DB >> 21895913

Single cysteine substitution in Bacillus thuringiensis Cry7Ba1 improves the crystal solubility and produces toxicity to Plutella xylostella larvae.

Donghai Peng1, Fenshan Wang, Nisha Li, Zhenyu Zhang, Rong Song, Zimin Zhu, Lifang Ruan, Ming Sun.   

Abstract

Many Bacillus thuringiensis isolates have no demonstrated toxicity against insects. In this study, a novel holotype crystal protein gene cry7Ba1 was isolated from a 'non-insecticidal'B. thuringiensis strain YBT-978. The Cry7Ba1 protein showed high toxicity against Plutella xylostella larvae after the crystals were dissolved at pH 12.5, suggesting that the 'non-insecticidal' properties of this protein were due to insolubility in the normal insect midgut pH environment. After the C-terminal half of Cry7Ba1 was replaced by that of Cry1Ac or Cry1C proteins, the recombinant protein inclusions could be dissolved at pH 9.5, and exhibited high toxicity against P. xylostella larvae. This result proved the insolubility of Cry7Ba1 crystal was determined by the structure of its C-terminal half. Further, six mutations were constructed by substituting cysteine residues with serine. Solubility studies showed that the crystals from mutants C697S, C834S and C854S could be dissolved at lower pH (10.5, 9.5 and 11.5 respectively). Bioassays showed that crystals from mutant C834S were toxic to P. xylostella larvae. Our discoveries suggest that a single cysteine residue located in the C-terminal half of the protein determines the solubility and toxicity of some nontoxic crystal proteins. This study provides a strategy to isolate novel insecticidal crystal protein genes from 'non-insecticidal'B. thuringiensis strains.
© 2011 Society for Applied Microbiology and Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895913     DOI: 10.1111/j.1462-2920.2011.02557.x

Source DB:  PubMed          Journal:  Environ Microbiol        ISSN: 1462-2912            Impact factor:   5.491


  6 in total

1.  Ser-substituted mutations of Cys residues in Bacillus thuringiensis Vip3Aa7 exert a negative effect on its insecticidal activity.

Authors:  Fang Dong; Shanshan Zhang; Ruiping Shi; Shuyuan Yi; Fangyan Xu; Ziduo Liu
Journal:  Curr Microbiol       Date:  2012-08-09       Impact factor: 2.188

2.  Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.

Authors:  Christopher A Seid; Kathryn M Jones; Jeroen Pollet; Brian Keegan; Elissa Hudspeth; Molly Hammond; Junfei Wei; C Patrick McAtee; Leroy Versteeg; Amanda Gutierrez; Zhuyun Liu; Bin Zhan; Jonathan L Respress; Ulrich Strych; Maria Elena Bottazzi; Peter J Hotez
Journal:  Hum Vaccin Immunother       Date:  2016-10-13       Impact factor: 3.452

3.  Efficient production of Bacillus thuringiensis Cry1AMod toxins under regulation of cry3Aa promoter and single cysteine mutations in the protoxin region.

Authors:  Blanca I García-Gómez; Jorge Sánchez; Diana L Martínez de Castro; Jorge E Ibarra; Alejandra Bravo; Mario Soberón
Journal:  Appl Environ Microbiol       Date:  2013-09-06       Impact factor: 4.792

4.  Improvement of crystal solubility and increasing toxicity against Caenorhabditis elegans by asparagine substitution in block 3 of Bacillus thuringiensis crystal protein Cry5Ba.

Authors:  Fenshan Wang; Yingying Liu; Fengjuan Zhang; Lujun Chai; Lifang Ruan; Donghai Peng; Ming Sun
Journal:  Appl Environ Microbiol       Date:  2012-08-03       Impact factor: 4.792

5.  The expression and crystallization of Cry65Aa require two C-termini, revealing a novel evolutionary strategy of Bacillus thuringiensis Cry proteins.

Authors:  Dong-hai Peng; Cui-yun Pang; Han Wu; Qiong Huang; Jin-shui Zheng; Ming Sun
Journal:  Sci Rep       Date:  2015-02-06       Impact factor: 4.379

6.  Complete Genome Sequence of Bacillus thuringiensis Serovar rongseni Reference Strain SCG04-02, a Strain Toxic to Plutella xylostella.

Authors:  Yajuan Fu; Yan Wu; Yihui Yuan; Meiying Gao
Journal:  Genome Announc       Date:  2017-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.